Measuring exacerbations in obstructive lung disease

Pharmacoepidemiology and Drug Safety

Volumn 19, Issue 4, 2010, Pages 367-374

  Velthove, Karin J ^a,b   Souverein, Patrick C ^a   Van Solinge, Wouter W ^a,b   Leufkens, Hubert G M ^a   Lammers, Jan Willem J ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Corticosteroid; Exacerbation; Hospitalization; Obstructive lung disease; Recurrent exacerbations

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LONG ACTING DRUG; MUSCARINIC RECEPTOR BLOCKING AGENT; SHORT ACTING DRUG; XANTHINE DERIVATIVE;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE MARKER; DRUG MEGADOSE; DRUG USE; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PHARMACOEPIDEMIOLOGY; PREDICTOR VARIABLE; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; COHORT STUDIES; DISEASE PROGRESSION; DRUG UTILIZATION REVIEW; FEMALE; HOSPITALIZATION; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; NETHERLANDS; PROGNOSIS; QUALITY OF LIFE; YOUNG ADULT;

EID: 77950879603     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1892     Document Type: Article

References (38)

1. From the Global Strategy for the Diagnosis Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2008; Available from: http://www.goldcopd.org.
2. From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA). 2008; Available from: http://www.ginasthma.org.
3. Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006; 28: 523-532. (Pubitemid 44794666)
4. Siva R, Green RH, Brightling CE, et al. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. Eur Respir J 2007; 29: 906-913. (Pubitemid 46711894)
5. Tattersfield A, Knox A, Britton J, et al. Asthma Lancet 2002; 360: 1313-1322.
6. Bousquet J, Cabrera P, Berkman N, et al. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. Allergy 2005; 60: 302-308. (Pubitemid 40293345)
7. Thomson NC, Chaudhuri R. Identification and management of adults with asthma prone to exacerbations: can we do better? BMC Pulm Med 2008; 8: 27.
8. Vermeire P, Rabe K, Soriano J, et al. Asthma control and differences in management practices across seven European countries. Respir Med 2002; 96: 142-149. (Pubitemid 35023683)
9. Sullivan SD, Rasouliyan L, Russo PA, et al. Extent, patterns, and burden of uncontrolled disease in severe or difficult-to-treat asthma. Allergy 2007; 62: 126-133. (Pubitemid 46090293)
10. FitzGerald JM, Gibson PG. Asthma exacerbations. 4: Prevention. Thorax 2006; 61: 992-999.
11. McKnight J, Scott A, Menzies D, et al. A cohort study showed that health insurance databases were accurate to distinguish chronic obstructive pulmonary disease from asthma and classify disease severity. J Clin Epidemiol 2005; 58: 206-208. (Pubitemid 40174931)
12. Blais L, Ernst P, Boivin JF, et al. Inhaled corticosteroids and the prevention of readmission to hospital for asthma. Am J Respir Crit Care Med 1998; 158: 126-132. (Pubitemid 28337169)
13. Ekberg-Aronsson M, Lofdahl K, Nilsson JA, et al. Hospital admission rates among men and women with symptoms of chronic bronchitis and airflow limitation corresponding to the GOLD stages of chronic obstructive pulmonary disease-a population-based study. Respir Med 2008; 102: 109-120. (Pubitemid 350153659)
14. Roede BM, Bresser P, Bindels PJ, et al. Antibiotic treatment is associated with reduced risk of a subsequent exacerbation in obstructive lung disease: an historical population based cohort study. Thorax 2008; 63: 968-973.
15. Gerrits CM, Herings RM, Leufkens HG, et al. Asthma exacerbations during first therapy with long acting beta 2-agonists. Pharm World Sci 1999; 21: 116-119.
16. Van Ganse E, van der Linden PD, Leufkens HG, et al. Asthma medications and disease exacerbations: an epidemiological study as a method for asthma surveillance. Eur Respir J 1995; 8: 1856-1860.
17. Boyter AC, Steinke DT. Changes in prescribing of inhaled corticosteroids (1999-2002) in Scotland. Pharmacoepidemiol Drug Saf 2005; 14: 203-209.
18. Herings RM, Bakker A, Stricker BH, et al. Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts. J Epidemiol Community Health 1992; 46: 136-140.
19. Breekveldt-Postma NS, Erkens JA, Aalbers R, et al. Extent of uncontrolled disease and associated medical costs in severe asthma-a PHARMO study. Curr Med Res Opin 2008; 24: 975-983. (Pubitemid 351579154)
20. Breekveldt-Postma NS, Gerrits CM, Lammers JW, et al. Persistence with inhaled corticosteroid therapy in daily practice. Respir Med 2004; 98: 752-759. (Pubitemid 38842778)
21. Rice KL, Rubins JB, Lebahn F, et al. Withdrawal of chronic systemic corticosteroids in patients with COPD: a randomized trial. Am J Respir Crit Care Med 2000; 162: 174-178. (Pubitemid 30469816)
22. Blais L, Suissa S, Boivin JF, et al. First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma. Thorax 1998; 53: 1025-1029. (Pubitemid 28567002)
23. Suissa S, Ernst P, Kezouh A. Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma. Thorax 2002; 57: 880-884. (Pubitemid 35178613)
24. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997; 50: 105-116.
25. Van Wijk BL, Klungel OH, Heerdink ER, et al. Initial non-compliance with antihypertensive monotherapy is followed by complete discontinuation of antihypertensive therapy. Pharmacoepidemiol Drug Saf 2006; 15: 587-593.
26. Gerrits CM, Herings RM, Leufkens HG, et al. N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease. Eur Respir J 2003; 21: 795-798. (Pubitemid 36592287)
27. Ten Brinke A, Sterk P, Masclee A, et al. Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J 2005; 26: 812-818. (Pubitemid 41632037)
28. Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol 1992; 45: 197-203.
29. Anderson HR, Gupta R, Strachan DP, et al. 50 years of asthma: UK trends from 1955 to 2004. Thorax 2007; 62: 85-90.
30. Frey U, Suki B. Complexity of chronic asthma and chronic obstructive pulmonary disease: implications for risk assessment, and disease progression and control. Lancet 2008; 372: 1088-1099.
31. De Vries F, Pouwels S, Bracke M, et al. Use of beta-2 agonists and risk of hip/femur fracture: a population-based case-control study. Pharmacoepidemiol Drug Saf 2007; 16: 612-619. (Pubitemid 47039527)
32. Blais L, Ernst P, Suissa S. Confounding by indication and channeling over time: the risks of beta 2-agonists. Am J Epidemiol 1996; 144: 1161-1169. (Pubitemid 26415107)
33. Czock D, Keller F, Rasche F, et al. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet 2005; 44: 61-98. (Pubitemid 40096038)
34. In 't Veen J, Smits H, Hiemstra P, et al. Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation bij double-blind steroid withdrawal. Am J Respir Crit Care Med 1999; 160: 93-99.
35. Pauwels RA. Similarities and differences in asthma and chronic obstructive pulmonary disease exacerbations. Proc Am Thorac Soc 2004; 1: 73-76.
36. Breekveldt-Postma NS, Koerselman J, Erkens JA, et al. Treatment with inhaled corticosteroids in asthma is too often discontinued. Pharmacoepidemiol Drug Saf 2008; 17: 411-422. (Pubitemid 351566360)
37. Tattersfield A, Postma D, Barnes P, et al. Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACETinternational Study Group. Am J Respir Crit Care Med 1999; 160: 594-599.
38. Menckeberg T. Adherence to inhaled corticosteroids and patient perception (dissertation), Utrecht University. 2008.